antibiotics Review FimH and Anti-Adhesive Therapeutics: A Disarming Strategy Against Uropathogens 1,2,3, 4, , 5, 6 Meysam Sarshar y , Payam Behzadi * y , Cecilia Ambrosi * , Carlo Zagaglia , Anna Teresa Palamara 1,5 and Daniela Scribano 6,7 1 Laboratory Affiliated to Institute Pasteur Italia-Cenci Bolognetti Foundation, Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy;
[email protected] (M.S.);
[email protected] (A.T.P.) 2 Research Laboratories, Bambino Gesù Children’s Hospital, IRCCS, 00146 Rome, Italy 3 Microbiology Research Center (MRC), Pasteur Institute of Iran, Tehran 1316943551, Iran 4 Department of Microbiology, College of Basic Sciences, Shahr-e-Qods Branch, Islamic Azad University, Tehran 37541-374, Iran 5 IRCCS San Raffaele Pisana, Department of Human Sciences and Promotion of the Quality of Life, San Raffaele Roma Open University, 00166 Rome, Italy 6 Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy;
[email protected] (C.Z.);
[email protected] (D.S.) 7 Dani Di Giò Foundation-Onlus, 00193 Rome, Italy * Correspondence:
[email protected] (P.B.);
[email protected] (C.A.) These authors contributed equally to this work. y Received: 30 June 2020; Accepted: 8 July 2020; Published: 10 July 2020 Abstract: Chaperone-usher fimbrial adhesins are powerful weapons against the uropathogens that allow the establishment of urinary tract infections (UTIs). As the antibiotic therapeutic strategy has become less effective in the treatment of uropathogen-related UTIs, the anti-adhesive molecules active against fimbrial adhesins, key determinants of urovirulence, are attractive alternatives.